This compound is a potent 5-lipoxygenase (5-LOX) inhibitor with potential for controlling inflammation, particularly in processes involving leukotriene biosynthesis, a key mediator of inflammation in chronic diseases such as asthma, rheumatoid arthritis, and atopic dermatitis.

Due to its properties in inhibiting inflammatory pathways, it is developed as a therapeutic agent for inflammation-based disorders, especially in oral or topical forms depending on absorption and body distribution.

Furthermore, studies in animal models have assessed its safety and efficacy, showing reduced inflammation without damage to mucosal or normal tissues, indicating potential for development into a drug with lower side effects compared to steroids or non-steroidal anti-inflammatory drugs (NSAIDs).